, a bio/informatics shared resource is still "open for business" - Visit the CDS website


Classification and Reporting of Potentially Proarrhythmic Common Genetic Variation in Long QT Syndrome Genetic Testing.

Giudicessi JR, Roden DM, Wilde AAM, Ackerman MJ
Circulation. 2018 137 (6): 619-630

PMID: 29431662 · PMCID: PMC6383807 · DOI:10.1161/CIRCULATIONAHA.117.030142

The acquired and congenital forms of long QT syndrome represent 2 distinct but clinically and genetically intertwined disorders of cardiac repolarization characterized by the shared final common pathway of QT interval prolongation and risk of potentially life-threatening arrhythmias. Over the past 2 decades, our understanding of the spectrum of genetic variation that (1) perturbs the function of cardiac ion channel macromolecular complexes and intracellular calcium-handling proteins, (2) underlies acquired/congenital long QT syndrome susceptibility, and (3) serves as a determinant of QT interval duration in the general population has grown exponentially. In turn, these molecular insights led to the development and increased utilization of clinically impactful genetic testing for congenital long QT syndrome. However, the widespread adoption and potential misinterpretation of the 2015 American College of Medical Genetics and Genomics variant classification and reporting guidelines may have contributed unintentionally to the reduced reporting of common genetic variants, with compelling epidemiological and functional evidence to support a potentially proarrhythmic role in patients with congenital and acquired long QT syndrome. As a result, some genetic testing reports may fail to convey the full extent of a patient's genetic susceptibility for a potentially life-threatening arrhythmia to the ordering healthcare professional. In this white paper, we examine the current classification and reporting (or lack thereof) of potentially proarrhythmic common genetic variants and investigate potential mechanisms to facilitate the reporting of these genetic variants without increasing the risk of diagnostic miscues.

© 2018 American Heart Association, Inc.

MeSH Terms (17)

Action Potentials Diagnostic Errors Genetic Predisposition to Disease Genetic Testing Genetic Variation Heart Conduction System Heart Rate Humans Long QT Syndrome NAV1.5 Voltage-Gated Sodium Channel Phenotype Potassium Channels, Voltage-Gated Predictive Value of Tests Prognosis Reproducibility of Results Risk Assessment Risk Factors

Connections (1)

This publication is referenced by other Labnodes entities:

Links